# FDA 483 - Memorial Hospital - Gulfport - February 04, 2019

Source: https://www.globalkeysolutions.net/records/483/memorial-hospital-gulfport/f1df3e18-c22d-4f60-a7c8-0b56a86b790e

> FDA 483 for Memorial Hospital - Gulfport on February 04, 2019. Product: biologics. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Memorial Hospital - Gulfport
- Inspection Date: 2019-02-04
- Product Type: biologics
- Office Name: New Orleans District Office
- Summary: An FDA inspection of Memorial Hospital At Gulfport Blood Bank revealed inadequate quality control procedures for supplies and reagents used in pre-transfusion testing. The firm's standard operating procedures failed to adequately describe QC testing profiles and handling of indeterminate test results for their blood bank analyzers. This indicates a significant deficiency in ensuring the reliability of critical pre-transfusion testing.

## Related Officers

- [Jason D Abel](https://www.globalkeysolutions.net/people/jason-d-abel/42c4bafe-17bb-4a43-80cd-83dd77b3426d)

Company: https://www.globalkeysolutions.net/companies/memorial-hospital-gulfport/d9335802-a000-4bc7-a8c9-61adf12eb34f

Office: https://www.globalkeysolutions.net/offices/new-orleans-district-office/95352142-b992-4e06-849d-d7483c0959ea